Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Zenith® fenestrert+ klinisk studie

1. oktober 2026 oppdatert av: Cook Research Incorporated

Zenith® fenestrert+ endovaskulær graft klinisk studie

The Zenith® Fenestrated+ Endovascular Graft Clinical Study will assess the safety and effectiveness of the Zenith® Fenestrated+ Endovascular Graft (ZFEN+) in combination with the BeGraft Balloon-Expandable FEVAR Bridging Stent Graft System (BeGraft) and Unibody2 for the treatment of patients with aortic aneurysms involving one or more of the major visceral arteries.

Up to 130 additional subjects may be enrolled in Continued Access phase of the study

Studieoversikt

Status

Rekruttering

Forhold

Intervensjon / Behandling

Studietype

Intervensjonell

Registrering (Antatt)

105

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Alabama
      • Birmingham, Alabama, Forente stater, 35294
        • Rekruttering
        • University of Alabama Birmingham Hospital
        • Ta kontakt med:
          • Adam Beck, MD
    • California
      • La Jolla, California, Forente stater, 92037
        • Rekruttering
        • UC San Diego
        • Ta kontakt med:
          • Mahmoud Malas, MD
      • Los Angeles, California, Forente stater, 90031
        • Rekruttering
        • University of Southern California
        • Ta kontakt med:
          • Sukgu Han, MD
      • Stanford, California, Forente stater, 94305
        • Rekruttering
        • Stanford Hospitals and Clinics
        • Ta kontakt med:
          • Jason Lee, MD
    • District of Columbia
      • Washington D.C., District of Columbia, Forente stater, 20010
        • Rekruttering
        • Medstar Washington Hospital Center
        • Ta kontakt med:
          • Steven Abramowitz, MD
    • Florida
      • Gainesville, Florida, Forente stater, 32610
        • Rekruttering
        • University of Florida Shands Hospital
        • Ta kontakt med:
          • Zain Shahid, MD
      • Tampa, Florida, Forente stater, 33606
        • Rekruttering
        • Tampa General Hospital
        • Ta kontakt med:
          • Dean Arnaoutakis, MD
    • Georgia
      • Atlanta, Georgia, Forente stater, 30322
        • Rekruttering
        • Emory University Hospital
        • Ta kontakt med:
          • Yazan Duwayri, MD
    • Illinois
      • Chicago, Illinois, Forente stater, 60611
        • Rekruttering
        • Northwestern Memorial Hospital
        • Ta kontakt med:
          • Neel Mansukhani, MD
      • Glenview, Illinois, Forente stater, 60026
        • Rekruttering
        • Endeavor Health Cardiovascular Institute at Glenbrook Hospital
        • Ta kontakt med:
          • George Pontikis
      • Maywood, Illinois, Forente stater, 60153
        • Rekruttering
        • Loyola University Medical Center
        • Ta kontakt med:
          • Michael Soult, MD
      • Naperville, Illinois, Forente stater, 60540
        • Rekruttering
        • Edward Hospital
        • Ta kontakt med:
          • George Pontikis, MD
        • Hovedetterforsker:
          • George Pontikis, MD
    • Indiana
      • Indianapolis, Indiana, Forente stater, 46202
        • Rekruttering
        • Methodist Hospital of Indiana
        • Ta kontakt med:
          • Andres Fajardo, MD
    • Maryland
      • Baltimore, Maryland, Forente stater, 21201
        • Rekruttering
        • University of Maryland
        • Ta kontakt med:
          • Shahab Toursavadkohi, MD
    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02215
        • Rekruttering
        • Beth Israel Deaconess Medical Center
        • Ta kontakt med:
          • Marc Schermerhorn, MD
      • Boston, Massachusetts, Forente stater, 02114
        • Fullført
        • Massachusetts General Hospital
      • Worcester, Massachusetts, Forente stater, 01655
        • Rekruttering
        • University of Massachusetts
        • Ta kontakt med:
          • Andres Schanzer, MD
    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48109
        • Rekruttering
        • University of Michigan Health System
        • Ta kontakt med:
          • Jonathan Eliason, MD
    • Minnesota
      • Rochester, Minnesota, Forente stater, 55905
        • Rekruttering
        • Mayo Clinic
        • Ta kontakt med:
          • Randall DeMartino, MD
    • Missouri
      • St Louis, Missouri, Forente stater, 63110
        • Rekruttering
        • Barnes Jewish Hospital
        • Ta kontakt med:
          • John Ohman, MD
    • New Hampshire
      • Lebanon, New Hampshire, Forente stater, 03756
        • Rekruttering
        • Dartmouth-Hitchcock Medical Center
        • Ta kontakt med:
          • Bjoern Suckow, MD
    • New York
      • New York, New York, Forente stater, 10016
        • Rekruttering
        • New York University Langone Medical Center
        • Ta kontakt med:
          • Thomas Maldonado, MD
      • New York, New York, Forente stater, 10032
        • Rekruttering
        • Columbia University Irving Medical Center/NY Presbyterian Hospital
        • Ta kontakt med:
          • Virenda Patel
    • North Carolina
      • Chapel Hill, North Carolina, Forente stater, 27599
        • Rekruttering
        • University of North Carolina at Chapel Hill
        • Ta kontakt med:
          • Federico Parodi, MD
    • Ohio
      • Cleveland, Ohio, Forente stater, 44195
        • Rekruttering
        • Cleveland Clinic Foundation
        • Ta kontakt med:
          • Francis Caputo, MD
    • Pennsylvania
      • Philadelphia, Pennsylvania, Forente stater, 19104
        • Rekruttering
        • Hospital of the University of Pennsylvania
        • Ta kontakt med:
          • Grace Wang, MD
      • Pittsburgh, Pennsylvania, Forente stater, 15213
        • Rekruttering
        • University of Pittsburgh Medical Center
        • Ta kontakt med:
          • Nathan Liang
    • South Carolina
      • Charleston, South Carolina, Forente stater, 29425
        • Rekruttering
        • Medical University of South Carolina
        • Ta kontakt med:
          • Ravi Veeraswamy, MD
    • Tennessee
      • Kingsport, Tennessee, Forente stater, 37660
        • Rekruttering
        • Holston Valley Hospital
        • Ta kontakt med:
          • Robert "Bo" Allen, MD
    • Texas
      • Dallas, Texas, Forente stater, 75235
        • Rekruttering
        • Ut Southwestern
        • Ta kontakt med:
          • Mirza Baig, MD
      • Houston, Texas, Forente stater, 77030
        • Rekruttering
        • Memorial Hermann Texas Medical Center/UT Health
        • Ta kontakt med:
          • Naveed Saqib, MD
    • Virginia
      • Roanoke, Virginia, Forente stater, 24014
        • Aktiv, ikke rekrutterende
        • Carilion Roanoke Memorial Hospital
      • London, Storbritannia, SE1 7EH
        • Aktiv, ikke rekrutterende
        • St Thomas' Hospital

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Include Criteria:

  1. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a diameter ≥ 55 mm for males and ≥ 50 mm for females
  2. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with a growth rate of ≥ 5 mm in 6 months
  3. Thoracoabdominal, pararenal or juxtarenal aortic aneurysm with aortic diameter > 2x the normal aortic diameter or saccular aneurysm that warrants treatment in the opinion of the investigator

Exclusion Criteria:

  1. Age < 18 years
  2. Life expectancy < 2 years
  3. Pregnant, breast-feeding, or planning to become pregnant within 60 months
  4. Inability or refusal to give informed consent by the patient or legally authorized representative
  5. Unwilling or unable to comply with the follow-up schedule, required clinical assessments, and imaging
  6. Simultaneous participation in another investigation study, unless the patient is at least 30 days beyond the primary endpoint of any previous study

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Aorta abdominal aneurisme

Endovascular aneurysm repair

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Composite measure of device technical success and procedural safety
Tidsramme: 30 days post procedure

Percent of patients with device technical success and freedom from procedural safety events in the following criteria:

  1. Device technical success which includes delivery, deployment, and withdrawal of the device without the need for unanticipated corrective intervention), and
  2. Freedom from the following procedural safety events: rupture, aneurysm-related mortality, permanent paraplegia, new onset renal failure requiring dialysis, bowel ischemia requiring surgery, and disabling stroke
30 days post procedure
Composite measure of freedom from aneurysm-related mortality and clinically significant reintervention
Tidsramme: 12 months post procedure

Percent of patients meeting the following criteria:

  1. Freedom from aneurysm-related mortality (death from aneurysm rupture, death from any cause occurring within 30 days of procedure or secondary intervention or device or procedure related death) and
  2. Freedom from clinically significant reintervention (including open surgery to restore blood flow or restore bodily function, any device related intervention requiring hospitalization, placement of an additional endovascular graft component(s), placement of a stent(s) as indicated for loss of or for having inadequate fixation, seal or patency)
12 months post procedure

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Etterforskere

  • Hovedetterforsker: Gustavo Oderich, MD, Baylor College of Medicine

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

8. desember 2023

Primær fullføring (Antatt)

1. november 2026

Studiet fullført (Antatt)

1. november 2031

Datoer for studieregistrering

Først innsendt

19. april 2021

Først innsendt som oppfylte QC-kriteriene

4. mai 2021

Først lagt ut (Faktiske)

6. mai 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

6. oktober 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

1. oktober 2026

Sist bekreftet

1. oktober 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 17-07

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

UBESLUTTE

IPD-planbeskrivelse

Cook Research Incorporated (CRI) is fully committed to supporting the principles of responsible data sharing, including providing qualified scientific researchers access to deidentified, patient-level data from CRI clinical studies to conduct legitimate scientific research. Data underlying the results reported in this clinical study will be made available for request after publication of the results from this study and ending 5 years after initial publication. Interested researchers may review the "Cook Research Incorporated Policy on Access to Clinical Study Data" at https://www.cookresearchinc.com/extranet/data-access.html and submit a complete research proposal to request data access. Additional study documents (such as the study protocol) will be shared as needed if the data access request is granted. A data sharing agreement will be executed for access to deidentified patient-level data.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Ja

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .